Article
AJMC® in the Press, January 14, 2022
Author(s):
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Findings of a study published online ahead of print in the July 2022 issue of The American Journal of Managed Care® were featured in an article published by Pharmacy Times. The study, “Projected US Savings From Biosimilars, 2021-2025,” indicated that projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020—driven primarily by new biosimilar entry. Savings were noted to be $124.5 billion under an upper-bound scenario. The findings were also covered by News Medical Life Sciences.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
